- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of appetite to treat obesity
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 4, Issue 2, Pages 243-259
Publisher
Informa UK Limited
Online
2011-03-15
DOI
10.1586/ecp.11.3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Behavior therapy for obesity: where are we now?
- (2011) David B Sarwer et al. Current Opinion in Endocrinology Diabetes and Obesity
- Benefit-Risk Assessment of Exenatide in the Therapy of Type 2 Diabetes Mellitus
- (2010) Baptist Gallwitz DRUG SAFETY
- The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
- (2010) Ya-Xiong Tao ENDOCRINE REVIEWS
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
- (2010) Cynthia L. Ogden JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
- (2010) William L Holland et al. NATURE MEDICINE
- Action Profile of the Antiobesity Drug Candidate Oleoyl-Estrone in Rats
- (2010) Sabine Strassburg et al. Obesity
- Recent advances in understanding leptin signaling and leptin resistance
- (2009) David L. Morris et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- New central targets for the treatment of obesity
- (2009) Bruce J. Sargent et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S
- (2009) JD Mitchell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance
- (2009) Lale Ozcan et al. Cell Metabolism
- Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
- (2009) R Krishna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gut Peptides: Targets for Antiobesity Drug Development?
- (2009) Timothy H. Moran et al. ENDOCRINOLOGY
- Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis
- (2009) Satoshi Mashiko et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Emerging technology: endoluminal treatment of obesity
- (2009) Gregory A. Coté et al. GASTROINTESTINAL ENDOSCOPY
- Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects
- (2008) C Beglinger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The epidemiology of obesity: the size of the problem
- (2008) W. P. T. James JOURNAL OF INTERNAL MEDICINE
- Targeting melanocortin receptors: an approach to treat weight disorders and sexual dysfunction
- (2008) Jarl E. S. Wikberg et al. NATURE REVIEWS DRUG DISCOVERY
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
- Lorcaserin (APD356), a Selective 5-HT2CAgonist, Reduces Body Weight in Obese Men and Women
- (2008) Steven R. Smith et al. Obesity
- Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides
- (2008) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies
- (2008) J. D. Roth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started